Table 4 Antibiotic resistance profile of staphylococci from Nigeria
| Â | Number (%) of isolates resistant among | |||
|---|---|---|---|---|
Antibiotics | MSSA | MRSA | S. haemolyticus | Others (CNS) |
n=36 | n=15 | n=21 | n=19 | |
Penicillin | 29 (80.6) | 15 (100) | 21 (100) | 18 (94.7) |
Oxacillin | 0 (0) | 15 (100) | 21 (100) | 12 (63.2) |
Teicoplanin | 0 (0) | 0 (0) | 1* (4.8) | 0 (0) |
Vancomycin | 0 (0) | 0 (00 | 0 (0) | 0 (0) |
Gentamicin | 0 (0) | 6 (40) | 18 (85.7) | 9 (47.4) |
Tetracycline | 21 (58.3) | 13 (86.7) | 19 (90.5) | 9 (47.4) |
Ciprofloxacin | 2 (5.6) | 7 (46.7) | 17 (80.9) | 9 (47.4) |
Moxifloxacin | 1 (2.8) | 1 (6.7) | 6 (28.6) | 3 (15.8) |
Erythromycin | 0 (0) | 5 (33.3) | 10 (47.6) | 0 (0) |
Clindamycin | 0 (0) | 5 (33.3) | 5 (23.8) | 0 (0) |
Fusidic acid | 0 (0) | 1 (6.7) | 1 (4.8) | 16 (84.2) |
Tigecycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Mupirocin | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Linezolid | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Rifampicin | 0 (0) | 2 (13.3) | 4 (19) | 0 (0) |
Cotrimoxazole | 29 (80.6) | 13 (86.7) | 21 (100) | 8 (42.1) |